Borosil Scientific Limited (NSE:BOROSCI)
India
· Delayed Price · Currency is INR 142.92
-2.87 (-1.97%)
At close: Jun 12, 2025, 3:30 PM IST
Borosil Scientific Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
| Operating Revenue | 4,385 | 3,946 | 980.43 | 1,062 | 651.95 | Upgrade
|
| Other Revenue | - | 14.06 | 3.65 | 2.32 | 2.08 | Upgrade
|
| Revenue | 4,385 | 3,960 | 984.08 | 1,064 | 654.02 | Upgrade
|
| Revenue Growth (YoY) | 10.73% | 302.39% | -7.54% | 62.73% | 33.32% | Upgrade
|
| Cost of Revenue | 1,615 | 1,469 | 444.72 | 473.04 | 291.11 | Upgrade
|
| Gross Profit | 2,770 | 2,491 | 539.37 | 591.27 | 362.91 | Upgrade
|
| Selling, General & Admin | 770.84 | 836.19 | 138.03 | 131.93 | 99.88 | Upgrade
|
| Other Operating Expenses | 1,473 | 1,187 | 305.91 | 288.93 | 192.22 | Upgrade
|
| Operating Expenses | 2,429 | 2,187 | 514.58 | 482.58 | 344.15 | Upgrade
|
| Operating Income | 341.21 | 304.01 | 24.79 | 108.7 | 18.76 | Upgrade
|
| Interest Expense | -15.46 | -27.02 | -3.28 | -3.12 | -6.33 | Upgrade
|
| Interest & Investment Income | - | 24.65 | 0.74 | 0.37 | 0.71 | Upgrade
|
| Currency Exchange Gain (Loss) | - | 5.41 | 1.07 | 2.16 | 0.3 | Upgrade
|
| Other Non Operating Income (Expenses) | 78.16 | 6.49 | 3.54 | 4.55 | 1.42 | Upgrade
|
| EBT Excluding Unusual Items | 403.91 | 313.54 | 26.86 | 112.66 | 14.85 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | 2.45 | 3.06 | 0.55 | - | Upgrade
|
| Gain (Loss) on Sale of Assets | - | -0.72 | -0.18 | - | - | Upgrade
|
| Other Unusual Items | - | 0.14 | - | - | - | Upgrade
|
| Pretax Income | 403.91 | 315.51 | 29.74 | 113.2 | 14.85 | Upgrade
|
| Income Tax Expense | 136.68 | 80.7 | 9.1 | 27.53 | 2.58 | Upgrade
|
| Earnings From Continuing Operations | 267.23 | 234.82 | 20.64 | 85.68 | 12.27 | Upgrade
|
| Minority Interest in Earnings | 0.81 | 0.77 | - | - | - | Upgrade
|
| Net Income | 268.04 | 235.59 | 20.64 | 85.68 | 12.27 | Upgrade
|
| Net Income to Common | 268.04 | 235.59 | 20.64 | 85.68 | 12.27 | Upgrade
|
| Net Income Growth | 13.78% | 1041.24% | -75.91% | 598.02% | - | Upgrade
|
| Shares Outstanding (Basic) | 89 | 89 | 2 | 1 | 1 | Upgrade
|
| Shares Outstanding (Diluted) | 89 | 89 | 2 | 1 | 1 | Upgrade
|
| Shares Change (YoY) | 0.02% | 5334.22% | 12.33% | 4.08% | 10.19% | Upgrade
|
| EPS (Basic) | 3.02 | 2.65 | 12.64 | 58.94 | 8.79 | Upgrade
|
| EPS (Diluted) | 3.02 | 2.65 | 12.64 | 58.94 | 8.79 | Upgrade
|
| EPS Growth | 13.96% | -79.03% | -78.55% | 570.67% | - | Upgrade
|
| Free Cash Flow | 1,059 | 171.27 | -223.9 | -39.44 | 12.17 | Upgrade
|
| Free Cash Flow Per Share | 11.93 | 1.93 | -137.11 | -27.13 | 8.71 | Upgrade
|
| Gross Margin | 63.17% | 62.91% | 54.81% | 55.55% | 55.49% | Upgrade
|
| Operating Margin | 7.78% | 7.68% | 2.52% | 10.21% | 2.87% | Upgrade
|
| Profit Margin | 6.11% | 5.95% | 2.10% | 8.05% | 1.88% | Upgrade
|
| Free Cash Flow Margin | 24.14% | 4.32% | -22.75% | -3.71% | 1.86% | Upgrade
|
| EBITDA | 525.95 | 452.22 | 95.43 | 170.4 | 70.75 | Upgrade
|
| EBITDA Margin | 12.00% | 11.42% | 9.70% | 16.01% | 10.82% | Upgrade
|
| D&A For EBITDA | 184.75 | 148.21 | 70.64 | 61.71 | 51.99 | Upgrade
|
| EBIT | 341.21 | 304.01 | 24.79 | 108.7 | 18.76 | Upgrade
|
| EBIT Margin | 7.78% | 7.68% | 2.52% | 10.21% | 2.87% | Upgrade
|
| Effective Tax Rate | 33.84% | 25.58% | 30.58% | 24.32% | 17.35% | Upgrade
|
| Revenue as Reported | 4,463 | 4,000 | 992.49 | 1,072 | 657.45 | Upgrade
|
| Advertising Expenses | - | 41.6 | 5.19 | 2.82 | 0.89 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.